Bladder cancer in 2010: how far have we come?

@article{Jacobs2010BladderCI,
  title={Bladder cancer in 2010: how far have we come?},
  author={Bruce L. Jacobs and Cheryl T. Lee and James E. Montie},
  journal={CA: a cancer journal for clinicians},
  year={2010},
  volume={60 4},
  pages={
          244-72
        }
}
  • Bruce L. Jacobs, Cheryl T. Lee, James E. Montie
  • Published 2010
  • Medicine
  • CA: a cancer journal for clinicians
  • Bladder cancer is the fourth most common cancer and ranks eighth as a cause of death from cancer among men in the United States. Although guidelines assist in treatment, the art of managing bladder cancer, such as the decision to use neoadjuvant chemotherapy and the timing of cystectomy, is still variable. Bladder cancer has a propensity to recur, and with recurrence, a significant number of cases progress, which makes the early detection of high-risk patients imperative. Advances in detection… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 287 CITATIONS, ESTIMATED 51% COVERAGE

    Pharmacogenomics in bladder cancer.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Research progress on bladder cancer molecular genetics.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    FILTER CITATIONS BY YEAR

    2010
    2020

    CITATION STATISTICS

    • 21 Highly Influenced Citations

    • Averaged 18 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 232 REFERENCES

    Bladder cancer from a perspective of 40 years.

    • Leopold G. Koss
    • Biology, Medicine
    • Journal of cellular biochemistry. Supplement
    • 1992